EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system

Yohei Hayashi, Suzu Oe, Yusuke Owaki, Tsutomu Miki, Keiichiro Kamura, Yan Lu, Momoko Kano, Yuki Fujisawa, Tomoka Takao, Atsuhiro Taguchi, Takeshi Takarada

Regenerative Therapy · 2026-12 · 33 · 101201

DOI: 10.1016/j.reth.2026.101201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regenerative Therapy, 2026-12. Verfasst von Yohei Hayashi und 10 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The generation of human induced pluripotent stem cells (hiPSCs) with homogeneous and stable quality at an affordable cost is key to industrialize hiPSC-based cell therapies and drug development; however, conventional manual production is labor-intensive and difficult to standardize. Automated closed-system approaches can improve reproducibility, reduce contamination risk, and enable scale-out manufacturing, yet concerns remain regarding the quality of hiPSCs produced using this approach specialized in hiPSC generation from peripheral blood cells.

Methods

Here we developed a prototype semi-automated hiPSC production system to generate polyclonal hiPSC lines from peripheral blood cells. The semi-automated device consists of a spiral microfluidic module for leukocyte separation, followed by modules for leukocyte expansion culture and the transduction of a Sendai virus (SeV) vector carrying reprogramming factors. Subsequently, the transduced leukocytes were manually cultured and expanded to generate polyclonal hiPSC lines.

Results

The generated polyclonal hiPSC populations maintained a normal karyotype and carried minimal residual SeV vector. Importantly, they exhibited self-renewing capacity and pluripotency comparable to those of established clonal hiPSC lines. Furthermore, when subjected to directed differentiation towards cartilage and kidney organoids, the polyclonal hiPSC lines efficiently differentiated into these lineages.

Conclusions

The semi-automated system enabled the generation of high-quality polyclonal hiPSC lines, which will hold promise for future applications in cell therapy and drug development.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency

Zitieren

APA

Hayashi, Y., Oe, S., Owaki, Y., Miki, T., Kamura, K., Lu, Y., Kano, M., Fujisawa, Y., Takao, T., Taguchi, A., & Takarada, T. (2026). Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system. Regenerative Therapy, 33, 101201. https://doi.org/10.1016/j.reth.2026.101201

Vancouver

Hayashi Y, Oe S, Owaki Y, Miki T, Kamura K, Lu Y, et al. Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system. Regenerative Therapy. 2026;33:101201. doi:10.1016/j.reth.2026.101201

BibTeX
@article{Hayashi2026,
  author = {Hayashi, Yohei and Oe, Suzu and Owaki, Yusuke and Miki, Tsutomu and Kamura, Keiichiro and Lu, Yan and Kano, Momoko and Fujisawa, Yuki and Takao, Tomoka and Taguchi, Atsuhiro and Takarada, Takeshi},
  title = {Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system},
  journal = {Regenerative Therapy},
  year = {2026},
  volume = {33},
  pages = {101201},
  doi = {10.1016/j.reth.2026.101201}
}
Kostenlos starten →